BioLife Solutions Names Pharmaceutical Industry Expert Kevin O'Donnell As Vice President, Cold Chain Standards, Practices & Compliance

Key Executive Will Support Adoption of biologistex Cold Chain Management Service and EVO Smart Containers for Temperature Sensitive Biologics

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), recently announced that pharmaceutical industry cold chain expert Kevin O'Donnell has joined the Company as Vice President, Cold Chain Standards, Practices & Compliance.

Most recently Kevin was a Senior Partner at Exelsius Cold Chain Management Consultancy, working at high levels within industry, international organizations, government agencies, and academia, to shape and improve the quality of healthcare product delivery through comprehensive good supply chain practices. In this role he provided consulting, research and training services to drug manufacturers, airlines, freight forwarders, supply chain goods and services providers and other stakeholders in the life science logistics sector.

Mike Rice, BioLife President & CEO, stated, "I am delighted that Kevin has joined our team and look forward to the immediate and many contributions he will make as we continue to fine tune our biologistex cold chain management service offering, which uses the SAVSU EVO smart container for transportation and tracking of temperature sensitive biologic materials throughout the delivery chain."

Kevin is recognized internationally as a key opinion leader focused on the development, promotion and implementation of industry best practices. He was awarded "Temperature Controlled Logistics Leader for 2012" by IQPC's Temperature Control Logistics & Quality Network, an international industry peer group recognizing 15 of the most influential and inspiring thought leaders in global pharmaceutical supply chain.

Kevin is also an elected member of the United States Pharmacopeia Convention Expert Committee for Packaging, Storage and Distribution and a recipient of the 2013 USP Award for Innovative Response to Public Health Challenges for outstanding work and leadership. He's a Temporary Advisor to the World Health Organization, a Certified Facilitator for the WHO/PDA Pharmaceutical Cold Chain Management on Wheels Course, and their ePELA Authentic e-Learning Course on Pharmaceutical Cold Chain Management.

About BioLife Solutions
BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services. The Company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. For more information, visit www.biolifesolutions.com.